Plasma factor VII: A potential marker of pre-eclampsia

Thrombosis Research

Volumn 127, Issue 1, 2011, Pages

  Dusse, Luci M ^a   Carvalho, Maria G ^a   Cooper, Alan J ^b,c   Lwaleed, Bashir A ^b,d  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

FVIIa; Plasma FVII; Pre eclampsia; TF; TFPI

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; OUTCOME ASSESSMENT; PARITY; PREDICTIVE VALUE; PREECLAMPSIA; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENGLAND; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR VII; FACTOR VIIA; FEMALE; HUMANS; LIPOPROTEINS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THROMBOPLASTIN; UP-REGULATION; YOUNG ADULT;

EID: 78650514205     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.10.022     Document Type: Article

References (31)

1. R.A. Fleck, L. Vijaya Mohan Rao, S.I. Rapaport, and N. Varki Localization of human tissue factor antigen by immuno-staining with monospecific, polychlonal anti-human tissue factor antibody Thromb Res 59 1990 421 437
2. A. Siegbahn Cellular consequences upon factor VIIa binding to tissue factor Haemostasis 30 2000 41 47
3. T.A. Drake, J.H. Morrissey, and T.A. Edgington Selective cellular expression of tissue factor in human tissues: Implication for disorders of haemostasis and thrombosis Am J Pathol 134 1989 1087 1097
4. Y. Nemerson, and R. Bach Tissue factor revisited Prog Hemost Thromb 6 1982 237 261
5. G.J. Broze The role of tissue factor pathway inhibitor in a revised coagulation cascade Semin Hematol 29 1992 159 169
6. S.I. Rapaport, and L.V. Rao Initiation and regulation of tissue factor-dependent blood coagulation Arterioscler Thromb 12 1992 1111 1121
7. B.A. Lwaleed, and P.S. Bass Tissue factor pathway inhibitor: structure, biology and involvement in disease J Pathol 208 2006 327 339
8. E.K. Kruithof, C. Tran-Thang, A. Gudinchet, J. Hauert, G. Nicoloso, and C. Genton Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors Blood 69 1987 460 466
9. A. Estelles, J. Gilabert, J. Aznar, D.J. Loskutoff, and R.R. Schleef Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia Blood 74 1989 1332 1338
10. A. Estelles, J. Gilabert, M. Keeton, Y. Eguchi, J. Aznar, and S. Grancha Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation Blood 84 1994 143 150
11. J. Djelmis, S. Kendic, D. Bukovic, D. Pfeifer, and M. Ivanisevic The effect of coagulation parameters on the placental respiratory and nutritive function in women having chronic hypertension with superimposed preeclampsia Coll Antropol 21 1997 127 137
12. K. Bremme, and M. Blombäck Hemostatic abnormalities may predict chronic hypertension after preeclampsia Gynecol Obstet Invest 41 1996 20 26
13. R. Schjetlein, M. Abdelnoor, G. Haugen, H. Husby, P.M. Sandset, and F. Wisloff Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia Acta Obstet Gynecol Scand 78 1999 191 197
14. M.A. Brown The physiology of pre-eclampsia Clin Exp Pharmacol Physiol 22 1995 781 791
15. P.W. Howie, C.B. Begg, D.W. Purdie, and C.R. Prentice Use of coagulation tests to predict the clinical progress of pre-eclampsia Lancet 2 1976 323 325
16. P.W. Howie The haemostatic mechanism in pre-eclampsia Clin Obstet Gynaecol 4 1977 595 611
17. P. Oian, I. Omsjo, J.M. Maltau, and B. Osterud Increased sensitivity to thromboplastin synthesis in blood monocytes from pre-eclamptic patients Br J Obstet Gynaecol 92 1985 511 517
18. P.M. Sandset, M. Hellgren, M. Uvebrandt, and H. Bergstrom Extrinsic coagulation pathway inhibitor and heparin cofactor II during normal and hypertensive pregnancy Thromb Res 55 1989 665 670
19. C.E. Metz Basic principles of ROC analysis Semin Nucl Med 8 1978 283 298
20. C.W. Redman, K.W. Denson, L.J. Beilin, F.G. Bolton, and G.M. Stirrat Factor-VIII consumption in pre-eclampsia Lancet 2 1977 1249 1252
21. T.W. Meade, G.J. Miller, and R.D. Rosenberg V. Fuster, M. Verstraete, Characteristics associated with the risk of arterial thrombosis and the pre-thrombotic state Thrombosis in Cardiovascular Disorders 1992 Saunders Philadelphia 79 97
22. J. Simon, A. Gray, and L. Duley Magpie Trial Collaborative Group. Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie Trial BJOG 113 2006 144 151
23. B. Osterud, and E. Bjorklid Human factor VII associated with endotoxin stimulated monocytes in whole blood Biochem Biophys Res Commun 108 1982 620 626
24. B. Osterud How to measure factor VII and factor VII activation Haemostasis 13 1983 161 168
25. J. Bonnar, G.P. McNicol, and A.S. Douglas Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia Br Med J 2 1973 12 16
26. R. Schjetlein, G. Haugen, and F. Wisloff Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation Acta Obstet Gynecol Scand 76 1997 541 546
27. R. Schjetlein, G. Haugen, P.M. Sandset, and F. Wisloff Reduced C4b-binding protein in preeclampsia Thromb Res 85 1997 153 158
28. B. Osterud, and S.I. Rapaport Synthesis of intrinsic factor X activator. Inhibition of the function of formed activator by antibodies to factor VIII and to factor IX Biochemistry 9 1970 1854 1861
29. K. Bremme, H. Wramsby, O. Andersson, M. Wallin, and M. Blomback Do lowered factor VII levels at extremely high endogenous oestradiol levels protect against thrombin formation? Blood Coagul Fibrinolysis 5 1994 205 210
30. I.A. Greer, N.G. Haddad, J. Dawes, F.D. Johnstone, and A.A. Calder Neutrophil activation in pregnancy-induced hypertension Br J Obstet Gynaecol 96 1989 978 982
31. M. Cignetti, G.G. Garzetti, F. Marchegiani, N. Fabris, and C. Romanini Natural killer cells and Tac antigen in the hypertension of pregnancy Clin Exp Obstet Gynecol 17 1990 13 15